Life Sciences

5 Small Cap Biotechs in Focus on World Cancer Day

Edward Kim | |

Each year on February 4th, World Cancer Day empowers all of us to show support, raise our collective voice, take personal action and press our governments to do more.

Eyenovia Shows Positive Phase 3 Results in Pupil Dilation Device

Edward Kim | |

80 million annual exams in the US involve mydriasis (pupil dilation)

Voyager Therapeutics Signs Deal with Neurocrine for Parkinson's Disease and Friedreich's Ataxia

Edward Kim | |

Voyager gets $165 million upfront + up to $1.7 billion in potential milestone payments

Biocept Launches Liquid Biopsy Research Kits for Cancer Gene Mutations

Edward Kim | |

Target Selector kits are research-use-only (RUO), to enable labs to leverage Biocept's patented assay technology for liquid biopsy testing

Seelos Therapeutics Gains Nasdaq Listing via Reverse Merger

Edward Kim | |

Central nervous system disorders, including suicidality and Parkinson's disease.

Agenus Closes Immuno-Oncology Deal with Gilead

Edward Kim | |

$150 million up front + up to $1.7 billion in milestone payments.

TG Therapeutics Gets Breakthrough Therapy Designation for Lymphoma Treatment

Edward Kim | |

Umbralisib is in Phase 3 trials in hematologic malignancies.

Avita Medical Begins Nationwide Launch of RECELL System for Severe Burns

Edward Kim | |

Company also closes 2nd tranche of AUD 40 million equity offering.

Aerpio Completes Patient Dosing in Phase 2b Diabetic Retinopathy Study

Edward Kim | |

Previous data has shown improvement in diabetic retinopathy and kidney function.

Alpine Immune Sciences Raises $25 Million in Private Placement of Stock + Warrants

Edward Kim | |

Company recently showed positive data in cancer and graft versus host disease.


Symbol Last Price Change % Change






INTERVIEW: CEO Dr. Martin Eaton - Heads Up Checkup Host & Contributor Silvia Davi interviewing CEO of Heads Up Checkup, Dr. Martin Eaton.